Eli Lilly Stock Pops on Drug Efficacy for Sleep Apnea

Eli Lilly And Co (NYSE:LLY) stock was last seen up 2.8% at $767.65, after the pharmaceutical giant said data from two late-stage trials showed its weight loss drug Mounjaro helped reduce irregular breathing in patients with obstructive sleep apnea.The security is on track to snap a four-day losing streak, and sports a whopping 106.1% year-over-year lead. Shares notched a March 4, all-time high of $800.78, with support from the $730 level, which has acted as a floor since early February.Short-term options tr ...